Aspen Aerogels(ASPN)
icon
搜索文档
Aspen Aerogels(ASPN) - 2020 Q2 - Earnings Call Transcript
2020-08-02 01:29
Aspen Aerogels, Inc. (NYSE:ASPN) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants John Fairbanks – Chief Financial Officer Don Young – President and Chief Executive Officer Conference Call Participants Eric Stine – Craig-Hallum Amit Dayal – H.C. Wainwright Jed Dorsheimer – Canaccord Genuity Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aspen Aerogels, Inc. 2Q 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. ...
Aspen Aerogels(ASPN) - 2020 Q1 - Quarterly Report
2020-05-05 05:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other jurisdict ...
Aspen Aerogels(ASPN) - 2020 Q1 - Earnings Call Transcript
2020-05-02 22:12
Aspen Aerogels, Inc. (NYSE:ASPN) Q1 2020 Earnings Conference Call April 30, 2020 5:00 PM ET Company Participants John Fairbanks - Chief Financial Officer Don Young - President and Chief Executive Officer Conference Call Participants Eric Stine - Craig-Hallum Thomas Curran - B. Riley FBR Sameer Joshi - H.C. Wainwright Jed Dorsheimer - Canaccord Genuity Operator Ladies and gentlemen, thank you for standing by and welcome to the Aspen Aerogels Incorporated Q1 2020 Earnings Conference Call. [Operator Instructio ...
Aspen Aerogels(ASPN) - 2019 Q4 - Annual Report
2020-03-07 05:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other jurisdiction o ...
Aspen Aerogels(ASPN) - 2019 Q4 - Earnings Call Transcript
2020-02-21 23:06
Aspen Aerogels, Inc. (NYSE:ASPN) Q4 2019 Earnings Conference Call February 20, 2020 5:00 PM ET Company Participants John Fairbanks - Chief Financial Officer Don Young - President & Chief Executive Officer Conference Call Participants Eric Stine - Craig-Hallum Chip Moore - Canaccord Thomas Curran - B. Riley FBR Amit Dayal - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by and welcome to the Aspen Aerogels Q4 Earnings Conference Call. At this time, all participants are in listen-only m ...
Aspen Aerogels(ASPN) - 2019 Q3 - Quarterly Report
2019-11-01 07:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol Name of exchange on which registered Common Stock ASPN The New York Stock Exchange FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ...